The World Health Organization (WHO) states that neurological diseases will account for over 12.22% of global deaths in 2030. As per the organization, cerebrovascular diseases, Alzheimer's and other dementia, Parkinson's diseases, epilepsy, tetanus, and meningitis will account for 10.63%, 0.92%, 0.23%, 0.19%, 0.13%, and 0.10% of global fatalities in 2030, respectively. Furthermore, the WHO states that nearly 2.5 billion people across the world will be living with some degree of hearing loss by 2050. At least 700 million of the affected population will require access to hearing and ear care and other rehabilitation services in the long run.

Thus, the rising prevalence of neurological and ear, nose, throat (ENT) disorders will help the surgical navigation system market to advance at 7.3% CAGR during 2019–2024. The market was valued at $770.8 million in 2018 and it is projected to generate $1,167.6 million revenue by 2024. Medical practitioners across the world are focusing on the application of surgical navigation systems for improved surgical procedures. Additionally, the surging cases of orthopedic illnesses, such as musculoskeletal disorders, will also augment the need for surgical navigation systems in the foreseeable future.

Report Description: https://www.psmarketresearch.com/market-analysis/surgical-navigation-system-market

Nowadays, augmented reality (AR) surgical navigation systems are being increasingly used in surgical procedures, as they can leverage virtual and actual reality technologies to guide healthcare professionals during such procedures. These systems provide high-quality visual information required for performing surgeries and diagnosing diseases, by integrating virtual anatomic structures, such as nerves, soft tissues, and blood vessels, with real-world in real time. The information procured through AR systems assists doctors in preparing pre-operative plans and performing surgeries with precision.

Surgical navigation system developers have been proactively engaging in product launches and collaborations to cater to more hospitals, clinics, and ambulatory settings. For instance, in May 2019, OrthAlign Corporation launched the HipAlign surgical navigation unit, which is used for performing total hip arthroplasty. Likewise, in September 2019, Medtronic plc introduced the Evolut PRO+ TAVR System in the U.S. This system is based on a supra-annular, self-expanding Evolut TAVR platform. With this product launch, the company aims to reach out to more customers in the U.S.